-
Mashup Score: 4Clinical trial tests vaccine for late-stage HPV-linked tumors - 4 year(s) ago
A phase I/II clinical trial at the NIH Clinical Center will test the effectiveness of a vaccine against cancers linked to the human papillomavirus (HPV). The vaccine will be tested alone and in combination with a checkpoint inhibitor called M7824. The phase I portion of the trial is currently recruiting between 12 and 18 people with advanced HPV-related cancer. They will be treated over a…
Source: Center for Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet
Delighted to work with Dr. Strauss and LTIB and @nciccr_gmb team on this therapeutic vaccine trial in #HPV associated malignancies, building on our #BintrafuspAlfa (#M7824) monotherapy data (in press in @jitcancer). @NCIResearchCtr https://t.co/7qGAG0JtnQ